tradingkey.logo

Transmedics Group Inc

TMDX
135.060USD
+5.460+4.21%
收盤 02/06, 16:00美東報價延遲15分鐘
4.61B總市值
49.90本益比TTM

Transmedics Group Inc

135.060
+5.460+4.21%

關於 Transmedics Group Inc 公司

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.

Transmedics Group Inc簡介

公司代碼TMDX
公司名稱Transmedics Group Inc
上市日期May 02, 2019
CEOHassanein (Waleed H)
員工數量728
證券類型Ordinary Share
年結日May 02
公司地址200 Minuteman Road
城市ANDOVER
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編01810
電話19785520900
網址https://www.transmedics.com/
公司代碼TMDX
上市日期May 02, 2019
CEOHassanein (Waleed H)

Transmedics Group Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Waleed H. Hassanein, M.D.
Dr. Waleed H. Hassanein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
481.61K
-47529.00%
Mr. James R. Tobin
Mr. James R. Tobin
Independent Chairman of the Board
Independent Chairman of the Board
177.21K
+2134.00%
Dr. David Weill, M.D.
Dr. David Weill, M.D.
Independent Director
Independent Director
12.13K
--
Mr. Nicholas (Nick) Corcoran
Mr. Nicholas (Nick) Corcoran
Senior Vice President - Supply Chain and Operations
Senior Vice President - Supply Chain and Operations
7.04K
-5640.00%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
4.06K
+2134.00%
Ms. Merilee Raines, CPA
Ms. Merilee Raines, CPA
Independent Director
Independent Director
4.06K
+2134.00%
Ms. Stephanie Lovell
Ms. Stephanie Lovell
Independent Director
Independent Director
4.06K
+2134.00%
Mr. Gerardo Hernandez
Mr. Gerardo Hernandez
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
331.00
-15653.00%
Dr. Tamer I. Khayal, M.D.
Dr. Tamer I. Khayal, M.D.
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Edward M. Basile
Mr. Edward M. Basile
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Waleed H. Hassanein, M.D.
Dr. Waleed H. Hassanein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
481.61K
-47529.00%
Mr. James R. Tobin
Mr. James R. Tobin
Independent Chairman of the Board
Independent Chairman of the Board
177.21K
+2134.00%
Dr. David Weill, M.D.
Dr. David Weill, M.D.
Independent Director
Independent Director
12.13K
--
Mr. Nicholas (Nick) Corcoran
Mr. Nicholas (Nick) Corcoran
Senior Vice President - Supply Chain and Operations
Senior Vice President - Supply Chain and Operations
7.04K
-5640.00%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
4.06K
+2134.00%
Ms. Merilee Raines, CPA
Ms. Merilee Raines, CPA
Independent Director
Independent Director
4.06K
+2134.00%

收入明細

單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
OCS Liver net revenue
107.94M
75.67%
OCS Heart net revenue
30.59M
21.44%
OCS Lung net revenue
4.11M
2.88%
地區USD
名稱
營收
佔比
United States
139.01M
97.46%
All other countries
3.63M
2.54%
業務
地區
業務USD
名稱
營收
佔比
OCS Liver net revenue
107.94M
75.67%
OCS Heart net revenue
30.59M
21.44%
OCS Lung net revenue
4.11M
2.88%

股東統計

更新時間: 1月31日 週六
更新時間: 1月31日 週六
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
13.86%
Fidelity Management & Research Company LLC
13.45%
The Vanguard Group, Inc.
10.53%
State Street Investment Management (US)
3.74%
Two Sigma Investments, LP
3.10%
其他
55.32%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
13.86%
Fidelity Management & Research Company LLC
13.45%
The Vanguard Group, Inc.
10.53%
State Street Investment Management (US)
3.74%
Two Sigma Investments, LP
3.10%
其他
55.32%
股東類型
持股股東
佔比
Investment Advisor
72.28%
Investment Advisor/Hedge Fund
23.64%
Hedge Fund
7.07%
Research Firm
4.62%
Individual Investor
2.95%
Bank and Trust
2.03%
Pension Fund
1.35%
Sovereign Wealth Fund
0.18%
Family Office
0.15%

機構持股

更新時間: 1月1日 週四
更新時間: 1月1日 週四
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
800
38.04M
111.30%
-5.53M
2025Q3
762
37.62M
110.09%
-8.17M
2025Q2
746
42.27M
124.01%
-2.30M
2025Q1
751
42.32M
125.08%
-2.32M
2024Q4
728
40.09M
119.11%
-642.74K
2024Q3
673
39.30M
117.10%
+1.37M
2024Q2
615
36.53M
110.85%
-3.27M
2024Q1
544
37.44M
113.97%
-4.28M
2023Q4
512
38.18M
116.94%
-3.46M
2023Q3
482
38.42M
117.77%
-240.92K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
4.74M
13.86%
+9.44K
+0.20%
Sep 30, 2025
Fidelity Management & Research Company LLC
4.60M
13.45%
-31.07K
-0.67%
Sep 30, 2025
The Vanguard Group, Inc.
3.60M
10.53%
+9.16K
+0.26%
Sep 30, 2025
State Street Investment Management (US)
1.28M
3.74%
-9.47K
-0.73%
Sep 30, 2025
Two Sigma Investments, LP
1.06M
3.1%
+366.05K
+52.85%
Sep 30, 2025
Nomura Investment Management Business Trust
906.27K
2.65%
-45.84K
-4.81%
Sep 30, 2025
Geode Capital Management, L.L.C.
813.57K
2.38%
+8.92K
+1.11%
Sep 30, 2025
Driehaus Capital Management, LLC
738.16K
2.16%
-115.88K
-13.57%
Sep 30, 2025
Hood River Capital Management LLC
678.44K
1.99%
-1.41K
-0.21%
Sep 30, 2025
Emerald Advisers LLC
626.03K
1.83%
-68.95K
-9.92%
Sep 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Global X HealthTech ETF
4.75%
Clough Select Equity ETF
2.87%
Invesco S&P SmallCap Health Care ETF
2.75%
State Street SPDR S&P Health Care Equipment ETF
2.18%
Invesco S&P SmallCap 600 Pure Growth ETF
1.54%
First Trust Nasdaq Lux Digi Health Solutions ETF
1.47%
iShares S&P Small-Cap 600 Growth ETF
0.63%
State Street SPDR S&P 600 Small Cap Growth ETF
0.61%
First Trust Multi-Manager Small Cap Opportunities ETF
0.58%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.58%
查看更多
Global X HealthTech ETF
佔比4.75%
Clough Select Equity ETF
佔比2.87%
Invesco S&P SmallCap Health Care ETF
佔比2.75%
State Street SPDR S&P Health Care Equipment ETF
佔比2.18%
Invesco S&P SmallCap 600 Pure Growth ETF
佔比1.54%
First Trust Nasdaq Lux Digi Health Solutions ETF
佔比1.47%
iShares S&P Small-Cap 600 Growth ETF
佔比0.63%
State Street SPDR S&P 600 Small Cap Growth ETF
佔比0.61%
First Trust Multi-Manager Small Cap Opportunities ETF
佔比0.58%
Vanguard S&P Small-Cap 600 Growth Index Fund
佔比0.58%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI